Literature DB >> 31391181

Outer retinal hyperreflective deposits (ORYD): a new OCT feature in naïve diabetic macular oedema after PPV with ILM peeling.

Matias Iglicki1, Anat Loewenstein2, Adiel Barak2, Shulamit Schwartz2, Dinah Zur2.   

Abstract

AIMS: We aimed to investigate a novel optical coherence tomography (OCT) finding of outer retinal hyperreflective deposits (ORYDs) in patients with naïve diabetic macular oedema (DMO) seen after small gauge pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling. Furthermore, we evaluated the predictive value of ORYD for visual outcome over 24 months follow-up.
METHODS: Retrospective cohort study including 111 eyes from 111 patients with naïve DMO treated by PPV and ILM peeling with a follow-up of 24 months. OCT scans were analysed for the presence of ORYD 1 week and 1, 6, 12, 18 and 24 months after surgery. Change in baseline best-corrected visual acuity (BCVA) and central subfoveal thickness (CST) after surgery were measured over the follow-up period. Presence of ORYD was correlated with baseline characteristics and BCVA after 24 months.
RESULTS: Hundred and eleven eyes from 111 patients were included (mean age 67.5±14.8 years). ORYD was identified in the outer plexiform layer as hyperreflective deposits in 92 patients (82.8%) 7 days after surgery but it was not present before surgery. There was a significant reduction in the presence of ORYD. After 24 months ORYD disappeared in all cases (p<0.001).
CONCLUSIONS: We describe a novel OCT feature of ORYD present in the early postoperative phase in the majority of patients after PPV with ILM peeling for naïve DMO, disappearing over the postoperative course. These deposits might be a result of sudden desinflammation and could shed new light on the process of DMO resolution after operative intervention. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  imaging; inflammation; retina; treatment surgery; vitreous

Year:  2019        PMID: 31391181     DOI: 10.1136/bjophthalmol-2019-314523

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Association of Paracentral Acute Middle Maculopathy with Visual Prognosis in Retinal Artery Occlusion: A Retrospective Cohort Study.

Authors:  Siying Liang; Qingshan Chen; Chenli Hu; Miaohong Chen
Journal:  J Ophthalmol       Date:  2022-05-21       Impact factor: 1.974

2.  Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant.

Authors:  Hung-Da Chou; Cheng-Hsiu Wu; Wei-Yu Chiang; Nan-Ni Chen; Yih-Shiou Hwang; Kuan-Jen Chen; Chien-Hsiung Lai; Pei-Chang Wu; Yi-Hao Chen; Ling Yeung; Shih-Chieh Shao; Chi-Chun Lai; Wei-Chi Wu
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

3.  First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review.

Authors:  Binyao Chen; Shizhao Yang; Wenru Su
Journal:  BMC Ophthalmol       Date:  2022-03-26       Impact factor: 2.209

4.  Prognostic Factors for Visual Outcomes in Closed Idiopathic Macular Holes after Vitrectomy: Outcomes at 4 Years in a Monocentric Study.

Authors:  Alexandre Lachance; Mélanie Hébert; Eunice You; Jean-Philippe Rozon; Serge Bourgault; Mathieu Caissie; Éric Tourville; Ali Dirani
Journal:  J Ophthalmol       Date:  2022-04-23       Impact factor: 1.974

5.  Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning.

Authors:  Ying Zhang; Fabao Xu; Zhenzhe Lin; Jiawei Wang; Chao Huang; Min Wei; Weibin Zhai; Jianqiao Li
Journal:  J Diabetes Res       Date:  2022-04-19       Impact factor: 4.061

6.  The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Li Xiaodong; Xie Xuejun
Journal:  J Ophthalmol       Date:  2022-08-09       Impact factor: 1.974

7.  Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates.

Authors:  Hsuan-Chieh Lin; Chung-May Yang; San-Ni Chen; Yi-Ting Hsieh
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.